Discover 1,438 paid clinical trials in Bradenton, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,438
FeaturedNew
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
for
Obesity, Overweight
Location: Clearwater FL, The Villages FL, Orlando FL,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT07752979
Phase2, Recruiting
Featured
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
for
Hemophilia A
Location: Tampa FL, Indianapolis IN, Iowa City IA, Aurora CO,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 12+
Code: NCT07416604
Phase3, Recruiting
Featured
A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
for
Atopic Dermatitis
Location: Tampa FL, Alpharetta GA, Camp Hill PA, Troy MI, London,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07223697
Phase2, Recruiting
Featured
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
for
Primary Open Angle Glaucoma
Location: Brandon FL, Jacksonville FL, Roswell GA, New Orleans LA,
Sponsor: AbbVie
Sex: All
Age: 45+
Code: NCT06822738
Phase3, Recruiting
Featured
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: Tampa FL, Lakeland FL, Lehigh Acres FL, Orlando FL,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819891
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Featured
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
for
Breast Cancer
Location: Tampa FL, Weston FL, Jacksonville FL, Tallahassee FL,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06790693
Phase3, Recruiting
Featured
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
for
Lymphoma
Location: Tampa FL, Coral Gables FL, Charlottesville VA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06084936
Phase3, Recruiting
Featured
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Tampa FL, Memphis TN, Houston TX, Fairfax VA,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT04302025
Phase2, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer
Location: Tampa FL, Rockledge FL, Jacksonville FL, Knoxville TN,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07155187
Phase2, Phase3, Recruiting
Featured
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Tampa FL, Fort Myers FL, Orlando FL, Mobile AL,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07365241
Phase3, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: Tampa FL, Atlanta GA, Houston TX, St Louis MO,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07581002
Phase2, Phase3, Recruiting
Featured
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Tampa FL, Ocala FL, Gainesville FL, Lexington KY,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07155174
Phase2, Recruiting
Featured
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
for
Colorectal Cancer
Location: Tampa FL, Newnan GA, Durham NC, Blacksburg VA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07525206
Phase3, Recruiting
Featured
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
for
Breast Cancer
Location: Tampa FL, Miami FL, Atlanta GA, Charlotte NC,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT07100106
Phase1, Phase2, Recruiting
Featured
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
for
Moderately to Severely Active Ulcerative Colitis
Location: Tampa FL, Atlanta GA, New York NY, Lake Success NY,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 2 - 17
Code: NCT07158242
Phase3, Recruiting
Featured
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
for
Migraine
Location: Tampa FL, Fort Myers FL, Orlando FL, Winter Park FL,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT05125302
Phase3, Recruiting
Featured
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
for
Parkinson's Disease
Location: Tampa FL, Orlando FL, Lady Lake FL, Maitland FL,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 50 - 70+
Code: NCT07174310
Phase3, Recruiting
Featured
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema